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The in vitro antitumour-promoting, cytotoxic, and antioxidant activities of two ester derivatives of garcinia acid, that is, 2-
(butoxycarbonylmethyl)-3-butoxycarbonyl-2-hydroxy-3-propanolide (1) and 1 ,1  -dibutyl methyl hydroxycitrate (2), that had
been previously isolated from the fruits of Garcinia atroviridis Griﬀ. ex T. Anders (Guttiferae), were examined. Based on the
inhibition of Epstein-Barr virus early antigen (EBV-EA) activation, compound 1 (IC50:7 0μM) showed much higher (8-fold)
antitumour-promoting activity than compound 2 (IC50: 560μM). In addition, both compounds were nontoxic towards CEM-
SS (human T-lymphoblastic leukemia) cells (CD50: >100μM), Raji (human B-lymphoblastoid) cells (CD50: >600μM), and brine
shrimp (LD50: >300μM). Although the antitumour-promoting activity of compound 1 is moderate compared with the known
antitumour promoter genistein, its non-toxicity suggests the potential of compound 1 and related structures as chemopreventive
agents. The weak antioxidant activity displayed by both compounds also suggested that the primary antitumour-promoting
mechanism of compound 1 did not involve oxidative-stress quenching.
1.Introduction
Garcinia atroviridis Griﬀ. ex T. Anders (Guttiferae) is a
medium-sized fruit tree endemic to Peninsular Malaysia.
This species grows wild throughout Peninsular Malaysia but
is also widely cultivated especially in the northern states
owing to its economic and medicinal values. In folkloric
medicine, G. atroviridis is used as a post-partum medication
and to treat earache, throat irritation, cough, dandruﬀ,a n d
stomach pains associated with pregnancy. Sun-dried slices of
the fruits are commercially available and are popularly used
asaseasoningincurries,sourrelishandalsofordressingﬁsh.
The young leaves are also used for culinary purposes and as
a traditional vegetable [1].
The occurrence of xanthones, benzophenones, and
biﬂavonoids is common in the Garcinia genus [2]. To date,
the metabolites that have been isolated from G. atroviridis
are atroviridin (xanthone); atrovirinone and 4-methylhy-
droatrovirinone (prenylated quinones); atrovirisidone and
atrovirisidone B (prenylated depsidones); along with the2 Evidence-Based Complementary and Alternative Medicine
known metabolites morelloﬂavone, fukugiside, naringenin,
3,8  -binaringenin, 14-cis-docosenoic acid, garcinia acid
(same as (−)-hydroxycitric acid) and its γ-lactone [3–7].
Garcinia acid, which has been primarily obtained from the
Garcinia genus, is an eﬀective inhibitor of lipogenesis with
commercial and clinical applications [8]. Previously, two
garcinia acid esters, namely, 2-(butoxycarbonylmethyl)-3-
butoxycarbonyl-2-hydroxy-3-propanolide and 1 ,1  -dibutyl
methyl hydroxycitrate (Figure 1) had been isolated from the
fruits of G. atroviridis, guided by antifungal activity against
Cladosporium herbarum [1, 9]. In this paper, we reported the
antitumour-promoting, antioxidant and cytotoxic activities
of both these compounds.
2.MaterialsandMethods
2.1. Source of Garcinia Acid Esters. The two esters deriva-
tives of garcinia acid, 2-(butoxycarbonylmethyl)-3-butox-
ycarbonyl-2-hydroxy-3-propanolide (1) and 1 ,1  -dibutyl
methyl hydroxycitrate (2), were available from our previous
isolation of these compounds from Garcinia atroviridis Griﬀ.
ex T. Anders (Guttiferae). Details of the isolation and identi-
ﬁcation were described in [1].
2.2. Culture of Cells. The CEM-SS (human T-lymphoblastic
leukemia) cell line was obtained from the National Cancer
Institute, USA, and the Raji (human B-lymphoblastoid)
cell line was provided by Prof. K. Koshimizu, Kinki Uni-
versity, Japan. Cells were cultured in RPMI-1640 (Sigma,
USA) medium with 10% v/v foetal calf serum (Sera Lab,
UK), 100IU/mL penicillin (Sigma, USA) and 100μg/mL
streptomycin (Sigma, USA) as a complete growth medium
(CGM). Cells were maintained in 25cm2 ﬂask with 10mL of
CGM at 37◦Cw i t h5 %C O 2. Every three days the cells were
subculturedbysplittingtheculturewithfreshCGMataratio
of 1:4 [10].
2.3. MTT Cytotoxicity Assay. Cytotoxicity was determined
using the MTT assay as reported by Ali et al. [10]. Varying
concentrations of the test compounds were prepared from
the stock solutions by serial dilution in RPMI-1640 to give
a volume of 100μL in each well of a microtiter plate (96-
w e l l )a sd e s c r i b e db e f o r e .E a c hw e l lw a sﬁ l l e dw i t h1 0 0 μl
of CEM-SS cell suspension in CGM at 1-2 × 105 cells/mL.
Controls that contained only CEM-SS cells were included
for each sample. The assay for each concentration of extract
was performed in triplicate and the culture plates were
kept at 37◦C with 5% (v/v) CO2 for three days. After 72h
of incubation, 100μLo fm e d i u mw a sr e m o v e df r o me a c h
well. Subsequently, 20μLo f0 . 5 %w / vM T T( S i g m a ,U S A )
dissolved in phosphate buﬀer saline was added to each
well and allowed to incubate for further 4h. After 4h of
incubation, 100μL of 1N hydrochloric acid:isopropanol
(1:24) was added to each well and vigorously mixed to
dissolve the formazan crystals. Absorbance values at 550nm
were measured with a microplate reader (Bio Tek EL 340,
USA) after background subtraction at 630nm. Cytotoxicity
was expressed as CD50, that is, the concentration to reduce
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Figure 1: The structures of the compound 1 (2-(butoxycarbon-
ylmethyl)-3-butoxycarbonyl-2-hydroxy-3-propanolide) and com-
pound 2(1 ,1  -dibutyl methyl hydroxycitrate).
the absorbance of treated cells by 50% with reference to the
control (untreated cells).
2.4. Brine Shrimp Lethality/Toxicity Assay. Brine shrimp
(Artemia saline Leach) eggs (Gold Eagle, USA) were placed
in a hatching tank containing sea water for 48h [11]. Each
compound (6μmol) was dissolved in 0.2mL methylene
chloride:methanol (1:1) to prepare a stock solution of
30mM. From the stock solutions, 50μL was transferred to
diﬀerent vials and allowed to evaporate. After evaporation,
5mL of brine was added to each vial in triplicate to prepare
a preliminary test concentration corresponding to 300μM.
Ten shrimp nauplii were added to each vial (30 shrimps per
concentration). The number of survivors out of 30 shrimps
per concentration was recorded.
2.5. In Vitro Antitumour-Promoting Assay. The inhibition
of Epstein-Barr virus (EBV) activation was used to eval-
uate in vitro antitumour-promoting activity [12]. Raji
cells were incubated for 48h at 37◦C under 5% CO2 in
1mL (∼5 × 105 cells) of RPMI-1640 medium containing
3mM sodium n-butyrate (Nacarai Tesque, Japan), 50nM
phorbol 12-myristate 13-acetate (PMA) (Sigma, USA) and
the test compounds (600μM) per well of a 24-well plate.
Conventional indirect immunoﬂuorescence staining of early
antigen (EA) with high-titre EA-positive serum (EA titre
1:1,280) obtained from nasopharyngeal carcinoma (NPC)
patients (1:20 serum dilution) followed by a 1:30 dilution
of ﬂuorescein-isothiocyanate-(FITC-)labeled IgG (Sigma,
USA) was used to measure EBV activation. The ratio of EA-
induced cells to the control experiments only with sodium
n-butyrate and PMA was around 50%. The test compounds
showing antitumour-promoting activity were serially diluted
(2-fold) to determine the IC50 values.Evidence-Based Complementary and Alternative Medicine 3
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Figure 2: Antioxidant activities of compounds 1 and 2. (a) FTC assay (i) absorbance at 500 nm, (ii) ratios of antioxidant values normalized
to α-tocopherol. (b) TBA assay (i) absorbance at 532nm, (ii) ratios of antioxidant values normalized to α-tocopherol. (c) DPPH assay. The
sample test concentrations in (a) to (c) are 0.6mM, 0.2mM, and 0.3mM, respectively. Assays were carried out in triplicate and averaged
(±0.1 absorbance units).
2.6. Antioxidant Assays
2.6.1. Ferric Thiocyanate (FTC) Method. A screw-cap vial
(∅ 38 × 75mm) containing a mixture of 4mg (4mL) of
a sample (ﬁnal concentration, 0.02%) in 99.5% ethanol,
4.1mL of 2.5% linoleic acid (TCL, Japan) in 99.5% ethanol,
8.0mL of 0.05M phosphate buﬀer (pH 7.0), and 3.9mL
of water was placed in an oven at 40◦C in the dark [13].
To 0.1mL of this mixture, 9.7mL of 75% (v/v) ethanol
and 0.1mL of 30% ammonium thiocyanate (Wako, Japan)
were added. Three minutes after the addition of 0.1mL of
2 × 10−2M ferrous chloride (Merck, Germany) in 3.5%
hydrochloric acid to the reaction mixture, the absorbance
was measured at 500nm (Spectronic 20D+, USA) each 24h
until one day after absorbance of the control reached its
maximum value. Antioxidant activity was represented by the
absorbance readings on the ﬁnal day of the assay (7th day)
(average of triplicates).
2.6.2. Thiobarbituric Acid (TBA) Method. Two mL of 20%
trichloroacetic acid (Fluka, Switzerland) and 2mL of 0.67%4 Evidence-Based Complementary and Alternative Medicine
TBA (Wako, Japan) solutions were added to 2.0mL from the
mixture (containing sample) prepared in the FTC method
[13]. This mixture was kept in a water bath (100◦C)
for 10min and, after cooling to room temperature, was
centrifuged at 3000rpm for 20min. Antioxidant activity
was based on the absorbance of the supernatant at 532nm
wavelength on the ﬁnal day of the FTC assay (average of
triplicates).
2.6.3. Radical Scavenging Method. T h em e t h a n o ls o l u t i o n
of 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH) (Aldrich
Chem. Co., USA) radicals (1mL, 0.3mM) was added to each
sample (1mM, 0.5mL) and was shaken vigorously [14]. The
absorbance of each sample was measured at 517nm after
allowing it to stand for 30min. Each sample (ﬁnal con-
centration, 0.3mM) was assayed in triplicate and averaged.
Standard antioxidants, that is, butylated hydroxytoluene
(BHT) and ascorbic acid, were used as positive controls.
3. Results andDiscussion
In the antitumour-promoting assay, compound 1,aβ-
lactone, strongly inhibited (IC50:7 0 μM) EBV activation
compared with compound 2 (IC50: 560μM). The IC50
of 1 was almost ﬁve-fold higher than the value of the
crude fruit extract (IC50:9 7 μg/mL). Compounds 1 and 2
were considered as nontoxic against CEM-SS and Raji cells
(CD50: >100μM). Both compounds were also inactive (LC50:
>300μM) in the brine shrimp lethality assay that is used as
an in vivo surrogate model for cytotoxicity. The antitumour-
promoting activity of 1 was noteworthy because of its
noncytotoxicity although it did not inhibit EBV activation
as strongly as the known antitumour-promoter, genistein
(IC50: ∼20μM), which is cytotoxic [15, 16]. Since inhibition
towards EBV-EA activation has been demonstrated to closely
parallelinvivoantitumourpromotion[17],compound1has
the potential as a chemopreventive agent.
The antioxidant assays performed on both compounds
showed weak activity that was slightly higher than the
control. Compounds 2 and 1, respectively, reduced oxidant
activity by 36 and 11% in the FTC assay (Figure 2(a)),
53 and 37% in the TBA assay (Figure 2(b)), and 5.5 and
3.4% in the DPPH assay (Figure 2(c)) but were weaker than
the positive control(s) especially in the radical scavenging
assay. It appeared that both these compounds were more
eﬀective inhibitors against late-stage oxidation as evidenced
by the stronger antioxidant activity in the TBA assay than the
FTC assay. The low antioxidant activity of both compounds
ruled out the inﬂuence of oxidative-stress quenching as
the dominant mechanism of action responsible for the
antitumour-promoting activity of the β-lactone, although
this mechanism is closely associated with antitumour-
promoting activity [18]. This was further conﬁrmed by the
recurring trend of 2 showing higher activity than 1 in all the
antioxidant assays whereas stronger antitumour-promoting
activity was displayed by 1 than 2.
4. Conclusions
Of the two new ester derivatives of garcinia acid, that
is, 2-(butoxycarbonylmethyl)-3-butoxycarbonyl-2-hydroxy-
3-propanolide (1)a n d1  ,1  -dibutyl methyl hydroxycitrate
(2),previouslyisolatedfromthefruitsofGarciniaatroviridis,
only compound 1 showed antitumour-promoting activity
althoughbothcompoundswereneithertoxicagainstthecells
tested and brine shrimp nor were particularly antioxidant.
This suggested the potential of compound 1 and related
structures as noncytotoxic chemopreventive agents.
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